Join the Scientific Update Newsletter

One training course – Three different perspectives  

We spoke to chemists at different stages of their careers about their experiences of attending our ‘Chemical Development and Scale Up in the Fine Chemical and Pharmaceutical Industries’ training course. Ben Littler  Ben told us that he had taken the ‘Chem Dev’ course twice as an early career process chemist!  Both courses were held as

Our Sadness on the Passing of Her Majesty The Queen

We are deeply saddened to hear of the passing of Her Majesty The Queen. She has been a constant in our lives and the only monarch we have known.  We would like to thank her for her dedicated service to her country and the Commonwealth for 70 years and send our heartfelt condolences to all

International Women’s Day 2022 – Scientific Update Ltd Leadership

To celebrate International Women’s Day 2022  – Helen Spencer (Consultant BDM and Marketer) asked Scientific Update Ltd joint owners and Directors Dr Claire Francis and Hannah May – a few questions about their career journey. Q: Do you think it is important to celebrate International Women’s Day? A: CF: Yes, for me it is an

Interview with Iwona Kaluzna from Innosyn

We recently had the pleasure of speaking with Iwona Kaluzna, Sales and Marketing Director at InnoSyn to learn about the key challenges and most exciting research areas in biocatalysis. Read the blog article by Laura Elizabeth Lansdowne, Senior Science Writer & Editor, Technology Networks: Link to article: Advances in Industrial Biocatalysis Iwona is presenting at

Enabling Synthesis in Fragment Based Drug Design (FBDD) with Emerging Technologies

Dr John Studley, Science Director at Scientific Update and Dr Rachel Grainger from Astex Pharmaceuticals got together ahead of our forthcoming Organic Process R&D Conference in Lisbon, Portugal on 23-25 September. Q: Dr John Studley (JS) Can you give us an overview of Fragment Based Drug Discovery (FBDD) and how you see the technique evolving over the next decade? A:

The Good, the Bad and the Ugly.

Dr John Studley, Science Director at Scientific Update and Dr William Goundry from Astra Zeneca got together ahead of our forthcoming Organic Process R&D Conference in Lisbon, Portugal on 23-25 September. Q: Dr John Studley (JS) We are looking forward to your presentation ‘The Good, the Bad and the Ugly! Successes and Failures from the

5 Minutes with Dr Boris Gorin, Eurofins Alphora

Dr John Studley, Scientific Director at Scientific Update recently spoke to Dr Boris Gorin, Eurofins Alphora, Toronto, Canada ahead of his presentation at the 2019 ‘Organic Process Research & Development’ Conference in Toronto, Canada. Boris will talk about “Eribulin Mesylate, a Journey from Synthetic Route Discovery to Scale-Up Manufacture”. John Studley (JS): Can you tell us a bit

19 Close

Filter